Projection of top 10 orphan drugs by global revenue 2024
Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)*
This statistic displays a projection of the top 10 global orphan drugs based on revenues in 2024. For that year, it is projected that Roche's and AbbVie's Venclexta will generate some 2.9 billion U.S. dollars in revenue. Orphan drugs are used to target rare diseases or disorders, which in the United States is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the United States through the Orphan Drug Act of 1983.
Projected top 10 orphan drugs worldwide by revenue in 2024 (in billion U.S. dollars)*
Source
More information
Statistics on "Orphan drugs"
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Top new orphan molecular entities by U.S. sales in 2019
- Italy: number of biotech orphan drugs drugs marketed 2016-2017, by type
- Required number of patients for phase III trials of orphan and non-orphan drugs 2015
- Median length of orphan and non-orphan drugs in phase III trial 2015
- Average FDA approved orphan drug sales U.S. 5 years after launch 2014
- Leading orphan designations in the EU by indication 2015
- Leading orphan drugs based on R&D phase III cost 2015
- Median length of time for orphan and non-orphan drugs for FDA approval 2015
- Orphan vs. non-orphan pipeline sales forecast worldwide 2019-2024
- Worldwide share of orphan drug sales by therapy category without oncology 2024
- Worldwide Rx drug sales excluding generics and orphan drugs 2002-2024
- Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Orphan drug sales worldwide excluding oncology by therapy category 2024
- Top U.S. cholesterol-lowering drugs by revenue market share 2013
- Greece: dressings packaged for medical use export value 2012-2017
- Manufacture of basic pharmaceutical products revenue in the United Kingdom 2010-2022
- Leading specialty therapy areas in the U.S. - utilization change 2016
- Industry revenue of »manufacture of pharmaceutical preparations« in Poland 2011-2023
- Manufacture of basic pharmaceutical products revenue in Slovenia 2010-2022
- Romania: medicament mixtures not in dosage import value 2012-2017
Statistics on "Orphan drugs"
Related topics
About Statista
